Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Acq. announced
Quarterly results
Consulting agrmnt
Appointed director

VYCOR MEDICAL INC (VYCO) Create: Alert

All | News | Filings
Date FiledTypeDescription
03/22/2021 8-K Quarterly results
06/30/2020 8-K Quarterly results
03/27/2020 8-K Quarterly results
Docs: "Vycor Medical Reports Financial Results for the year ended December 31st , 2019 BOCA RATON, FL – Vycor Medical, Inc. , a provider of innovative and superior surgical and therapeutic solutions, reported financial results for the year ended December 31, 2019."
03/29/2019 8-K Quarterly results
10/12/2018 8-K Quarterly results
03/30/2018 8-K Quarterly results
11/13/2017 8-K Quarterly results
08/11/2017 8-K Quarterly results
05/11/2017 8-K Form 8-K - Current report
03/31/2017 8-K Form 8-K - Current report
02/27/2017 8-K Form 8-K - Current report
01/12/2017 8-K Form 8-K - Current report
11/14/2016 8-K Form 8-K - Current report
08/09/2016 8-K Form 8-K - Current report
04/28/2016 8-K Form 8-K - Current report
03/30/2016 8-K Quarterly results
Docs: "[email protected]",
"SHAREHOLDER LETTER"
11/13/2015 8-K Quarterly results
Docs: "Vycor Medical Reports Third Quarter 2015 Results BOCA RATON, FL – Vycor Medical, Inc. , a provider of innovative and superior surgical and therapeutic solutions, reported financial results for the third quarter and first nine months ended September 30, 2015. Operational Highlights NovaVision ● Novavision’s VRT has hitherto been, in effect, a prototype with a delivery and service model too costly to be affordable and scalable. NovaVision’s development strategy has been to reduce the cost of therapy delivery and make it more efficient and therefore scalable, migrating therapy delivery from provided-hardware to Internet-delivered onto patients' computers; and to broaden patient benefits by adding its new NeuroEyeCoach compensation therapy to complement the VRT restoration therapy in a s..."
08/14/2015 8-K Quarterly results
Docs: "Vycor Medical Releases Financial Results for the three and six months ended June 30st, 2015 BOCA RATON, FL – Vycor Medical, Inc. , a provider of innovative and superior surgical and therapeutic solutions, reported financial results for the second quarter and first half ended June 30, 2015. Operational Highlights NovaVision ● Launched NovaVision’s new Internet-delivered therapy suite in the U.S. This therapy suite consists of two highly complementary therapies: Vision Restoration Therapy , the only FDA-approved medical therapy aimed at the restoration of vision lost as a result of neurological damage, and NeuroEyeCoach, an eye-movement compensation therapy. The suite is delivered directly to patients’ computers over the Internet. ● Expanded its agreement with HealthSouth, one of..."
07/24/2015 8-K Other Events, Financial Statements and Exhibits
05/15/2015 8-K Quarterly results
Docs: "VYCOR MEDICAL, INC. PRESS RELEASE DATED MAY 15, 2015"
03/31/2015 8-K Quarterly results
11/12/2014 8-K Quarterly results
Docs: "Vycor Medical Releases Financial Results for Third Quarter and First Nine Months of 2014"
08/12/2014 8-K Quarterly results
Docs: "Vycor Reports 41% Year-to-Date Growth"
08/08/2014 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Material Modifications to Rights of Secu...
Docs: "Certificate of Designations for Vycor Medical, Inc. Series D Convertible Preferred Stock",
"Form of Securities Exchange Agreement by and between Vycor Medical, Inc. and Fountainhead Capital Management Limited",
"Form of Agreement by and between Vycor Medical, Inc. and Fountainhead Capital Management Limited",
"Form of Vycor Medical, Inc. Series A Warrant",
"Form of Vycor Medical, Inc. Series B Warrant",
"Vycor Medical Boosts Shareholder Equity by $2.4 million"
05/19/2014 8-K Quarterly results
Docs: "Form of Amendment and Waiver Agreement with Investors",
"Form of Amendment and Waiver Agreement with Placement Agent"
04/30/2014 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits
Docs: "Press Release dated April 28, 2014 Vycor Medical Completes Equity Offering"
03/10/2014 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits
Docs: "Vycor Medical, Inc. Certificate of Correction filed on February 28, 2014"
02/04/2014 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities
01/07/2014 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Departure of Directors or Certain Office...
Docs: "Form of Investor Series A Warrant",
"Form of Investor Series B Warrant",
"Form of Placement Agent Warrant",
"Form of Securities Purchase Agreement between the Company and the Investors",
"Registration Rights Agreement",
"Placement Agent Agreement by and between the Company and the Placement Agent",
"Vycor Medical Completes Initial Close of Equity Offering"
05/03/2013 8-K Form 8-K - Current report
01/17/2013 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits
12/21/2012 8-K Form 8-K - Current report
12/05/2012 8-K Submission of Matters to a Vote of Security Holders
07/09/2012 8-K Form 8-K - Current report
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy